NCT04861103View on ClinicalTrials.gov

Anticoagulation Profile in Pregnant Women Treated with Three Times a Day of Low Molecular Weight Heparin (LMWH)

PHASE4RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Pregnancy, High RiskAnticoagulants
Interventions
DRUG

Lovenox

Three times a day dosing and measuring Xa peak and trough levels

Trial Locations (1)

92868

RECRUITING

University of California Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER